Monsanto and Bayer merger gains shareholder approval
Monsanto shareholders voted about 99 percent in favor of the proposed merger with Bayer at a special meeting in Creve Coeur Missouri. The deal values at 128 dollars per share and requires antitrust clearance by year end 2017 with regulatory filings already in progress in the United States.
MENTIONED IN THIS ARTICLE
Monsanto
Bayer
Creve Coeur
Hugh Grant
United States
Europe
Brazil
India
China
Grant
Natural Resources Defense Council
New York Stock Exchange
HUD probe clouds Treasury pick Mnuchin’s credibility
The HUD investigation into foreclosures at the OneWest unit Financial Freedom raises questions about Steven Mnuchin’s record as CEO and his severance, leaving lawmakers wary of his Treasury nomination. Cit Group faces accounting issues and unit sale talks while Mnuchin’s exit remains under scrutiny.
MENTIONED IN THIS ARTICLE
Donald Trump
Treasury
Steven Mnuchin
California
Mnuchin
One- West Bank
U.S. Department of Housing and Urban Development
CIT Group Inc
CIT
Ellen Alemany
Financial Freedom
Alemany
OneWest
Bloomberg
HUD
Senate
Ron Wyden
Oregon
Senate Finance Committee
Treasury Department
Deal pressures CBS Viacom as scale drives talks of partnerships
National Amusements Inc. has abandoned plans to merge CBS Corp and Viacom, citing a desire to retain control while signaling possible partnerships or acquisitions to stay competitive. Shari Redstone and Sumner Redstone stress scale, with CBS and Viacom not eager for large deals but facing industry pressure. Analysts note strategic alliances could finance bigger film slates if Viacom stays independent.
MENTIONED IN THIS ARTICLE
Sumner Redstone
National Amusements Inc
CBS Corp
Viacom Inc
Redstone
Shari
CBS
Viacom
National Amusements
New York Times
Brean Murray
Alan Gould
U.S
At&t Inc
Time Warner Inc
Rupert Murdoch
Twenty-First Century Fox Inc
Sky PLC
Eli Lilly Offers 40 Percent Insulin Discount For Uninsured
Eli Lilly announced a 40 percent discount on insulin for patients paying full retail price starting in January. The program, via Blink Health, targets uninsured or high deductible plans and follows public scrutiny over insulin costs.
MENTIONED IN THIS ARTICLE
Eli Lilly and Co
Novo Nordisk
Eli Lilly
Blink Health
Lilly
Bernie Sanders
I-Vt
Elijah Cummings
D-Md
Also Mentioned on This Page
Agribusiness
OK Bayer
Mons
Reuters
OneWest Bank
Consumer Financial Protection Bureau
Trump Tower
New York
Cbs-Viacom
Washington Post